{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T07:06:28Z","timestamp":1768892788374,"version":"3.49.0"},"reference-count":37,"publisher":"Informa UK Limited","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Medical Research and Opinion"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1185\/030079906x100131","type":"journal-article","created":{"date-parts":[[2006,3,25]],"date-time":"2006-03-25T17:15:00Z","timestamp":1143306900000},"page":"823-835","source":"Crossref","is-referenced-by-count":22,"title":["Consistency of lipid-altering effects of ezetimibe\/simvastatin across gender, race, age, baseline low density lipoprotein cholesterol levels, and coronary heart disease status: results of a pooled retrospective analysis"],"prefix":"10.1185","volume":"22","author":[{"given":"Leiv","family":"Ose","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arvind","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Davies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Rotonda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darbie","family":"Maccubbin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane","family":"Tribble","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrico","family":"Veltri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yale","family":"Mitchel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2006,3,23]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.19.2486"},{"key":"CIT0002","first-page":"1601","volume":"24","author":"De Backer G","year":"2003","journal-title":"European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000133317.49796.0E"},{"key":"CIT0004","first-page":"2405","volume":"162","author":"Law MR","year":"2002","journal-title":"The underlying risk of death after myocardial infarction in the absence of treatment. Arch Intern Med"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199006143222403"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199807233390404"},{"key":"CIT0007","first-page":"1615","volume":"279","author":"Downs JR","year":"1998","journal-title":"Air Force\/Texas Coronary Atherosclerosis Prevention Study. JAMA"},{"key":"CIT0008","first-page":"1301","volume":"333","author":"Shepherd J","year":"1995","journal-title":"West of Scotland Coronary Prevention Study Group. N Engl J Med"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199811053391902"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16895-5"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)09327-3"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)12948-0"},{"key":"CIT0013","first-page":"1383","volume":"344","author":"Scandinavian Simvastatin Survival Study Group","year":"1994","journal-title":"Lancet"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)11600-X"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(98)00202-2"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(86)90155-9"},{"key":"CIT0018","first-page":"263","volume":"20","author":"Mungall MM","year":"2003","journal-title":"Shepherd J. Statin therapy in the elderly: does it make good clinical and economic sense? Drugs Aging"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2004.11.055"},{"key":"CIT0020","first-page":"343","volume":"160","author":"Miller M","year":"2000","journal-title":"Prospective Randomized Evaluation of the Vascular Effects of Norvasc Trial (PREVENT) Investigators. Arch Intern Med"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2003.04.003"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.96.12.4211"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1001\/jama.288.23.2998"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.160.4.459"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199908123410707"},{"key":"CIT0026","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0022-3565(24)36992-7","volume":"283","author":"Van Heek M","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1016\/S0195-668X(02)00807-2"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1111\/j.1368-5031.2004.00289.x"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1089\/jwh.2004.13.1101"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.2165\/00002512-200421150-00005"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.103.13.1813"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2004.11.016"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2004.02.060"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2004.02.059"},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2004.11.023"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(02)02610-4"},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.4065\/79.5.620"},{"key":"CIT0038","first-page":"234","volume":"149","author":"Kastelein JJ","year":"2005","journal-title":"Design and rationale of the Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression (ENHANCE) trial. Am Heart J"}],"container-title":["Current Medical Research and Opinion"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1185\/030079906X100131","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T04:16:23Z","timestamp":1736309783000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1185\/030079906X100131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3,23]]},"references-count":37,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2006,3,23]]},"published-print":{"date-parts":[[2006,5]]}},"alternative-id":["10.1185\/030079906X100131"],"URL":"https:\/\/doi.org\/10.1185\/030079906x100131","relation":{},"ISSN":["0300-7995","1473-4877"],"issn-type":[{"value":"0300-7995","type":"print"},{"value":"1473-4877","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,3,23]]}}}